Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis
Back
14 Apr 2024
16:00
16:30
Spotlight Stage 1 (exhibition hall)
Brad
Rovin
Spotlight Speaker
United States
The Ohio State University
Uptal
Patel
Spotlight Speaker
United States
Add to My Schedule
Rationale for anti-CD38 therapy in Lupus Nephritis
Overview of Felzartamab and current Ph1b Lupus Nephritis trial design